{"success":true,"data":{"pressRelease":{"id":"17230","rtpr_id":"nPn4bxyq4a","ticker":"GOSS","exchange":"NASDAQ","all_tickers":["GOSS"],"title":"GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026","author":"PR Newswire","published_at":"2026-05-01T14:03:00.022Z","article_body":"GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026\n\nPR Newswire\n\nNEW YORK, May 1, 2026\n\nFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3530188945&u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&a=James+(Josh)+Wilson)\nEncourages Investors Who Suffered Losses In Gossamer To Contact Him Directly\nTo Discuss Their Options\n\nIf you purchased or acquired securities in Gossamer\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=4131884504&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=Gossamer)\nbetween June 16, 2025 and February 20, 2026 and would like to discuss your\nlegal rights, call Faruqi & Faruqi partner Josh Wilson directly at\n877-247-4292 or 212-983-9330 (Ext. 1310).\n\n[You may also click here for additional information]\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=86675342&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=%5BYou+may+also+click+here+for+additional+information%5D)\n\nNEW YORK, May 1, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1030381571&u=https%3A%2F%2Fwww.faruqilaw.com%2F&a=Faruqi+%26+Faruqi%2C+LLP)\n, a leading national securities law firm, is investigating potential claims\nagainst Gossamer Bio, Inc. (\"Gossamer\" or the \"Company\") (NASDAQ: GOSS) and\nreminds investors of the June 1, 2026 deadline to seek the role of lead\nplaintiff in a federal securities class action that has been filed against the\nCompany.\n\n(https://mma.prnewswire.com/media/2457438/Faruqi_Logo.html)\n\nFaruqi & Faruqi is a leading national securities law firm with offices in\nNew York, Pennsylvania, California and Georgia. The firm has recovered\nhundreds of millions of dollars for investors since its founding in 1995. See\nwww.faruqilaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=601935371&u=https%3A%2F%2Fwww.faruqilaw.com%2F&a=www.faruqilaw.com)\n.\n\nAs detailed below, the complaint alleges that the Company and its executives\nviolated federal securities laws by making false and/or misleading statements\nand/or failing to disclose that the study design for the Company's Phase 3\nPROSERA study, particularly, controlling for the placebo response at the Latin\nAmerican testing sites.\n\nOn February 23, 2026, Gossamer Bio, Inc. revealed adverse topline results from\nits Phase 3 PROSERA study, announcing that the trial failed to meet its\nprimary endpoint of improving six-minute walk distance (\"6MWD\") at Week 24.\nWhile the study reported a placebo-adjusted gain of +13.3 meters, the result\ndid not achieve statistical significance under the prespecified alpha\nthreshold of 0.025 (p=0.0320). The Company attributed the outcome, in part, to\nunexpectedly strong placebo performance among patients enrolled at Latin\nAmerican sites, which it characterized as a heavily treated, lower-risk\npopulation.\n\nFollowing this disclosure, investors and analysts reacted swiftly and\nnegatively. On February 23, 2026, Gossamer's common stock price plummeted from\na closing price of $2.13 per share on February 20, 2026 to $0.42 per share,\nrepresenting a decline of more than 80% in a single trading day.\n\nThe court-appointed lead plaintiff is the investor with the largest financial\ninterest in the relief sought by the class who is adequate and typical of\nclass members who directs and oversees the litigation on behalf of the\nputative class. Any member of the putative class may move the Court to serve\nas lead plaintiff through counsel of their choice, or may choose to do nothing\nand remain an absent class member. Your ability to share in any recovery is\nnot affected by the decision to serve as a lead plaintiff or not.\n\nFaruqi & Faruqi, LLP also encourages anyone with information regarding\nGossamer's conduct to contact the firm, including whistleblowers, former\nemployees, shareholders and others.\n\nTo learn more about the Gossamer Bio class action, go to\nwww.faruqilaw.com/GOSS\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1719973099&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=www.faruqilaw.com%2FGOSS)\nor call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or\n212-983-9330 (Ext. 1310).\n\nFollow us for updates on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=672128528&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ffaruqi-%26-faruqi-llp%2F&a=LinkedIn)\n, on X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1346472736&u=https%3A%2F%2Fx.com%2Ffaruqilaw&a=X)\n, or on Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3798677373&u=https%3A%2F%2Fwww.facebook.com%2FFaruqiLaw%2F&a=Facebook)\n.\n\nAttorney Advertising. The law firm responsible for this advertisement is\nFaruqi & Faruqi, LLP (www.faruqilaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3895810712&u=http%3A%2F%2Fwww.faruqilaw.com%2F&a=www.faruqilaw.com)\n). Prior results do not guarantee or predict a similar outcome with respect to\nany future matter. We welcome the opportunity to discuss your particular case.\nAll communications will be treated in a confidential manner.\n\n(https://mma.prnewswire.com/media/2745617/Faruqi__Faruqi_LLP_James_Josh_Wilson.html)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/goss-shareholder-reminder-faruqi--faruqi-llp-reminds-gossamer-bio-goss-investors-of-securities-class-action-deadline-on-june-1-2026-302759781.html\n(https://www.prnewswire.com/news-releases/goss-shareholder-reminder-faruqi--faruqi-llp-reminds-gossamer-bio-goss-investors-of-securities-class-action-deadline-on-june-1-2026-302759781.html)\n\nSOURCE Faruqi & Faruqi, LLP\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2457438/Faruqi_Logo.jpg\nhttps://mma.prnewswire.com/media/2745617/Faruqi__Faruqi_LLP_James_Josh_Wilson.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn4bxyq4a","title":"GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026","author":"PR Newswire","ticker":"GOSS","created":"2026-05-01T14:03:00.022Z","tickers":["GOSS"],"exchange":"NASDAQ","article_body":"GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026\n\nPR Newswire\n\nNEW YORK, May 1, 2026\n\nFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3530188945&u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&a=James+(Josh)+Wilson)\nEncourages Investors Who Suffered Losses In Gossamer To Contact Him Directly\nTo Discuss Their Options\n\nIf you purchased or acquired securities in Gossamer\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=4131884504&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=Gossamer)\nbetween June 16, 2025 and February 20, 2026 and would like to discuss your\nlegal rights, call Faruqi & Faruqi partner Josh Wilson directly at\n877-247-4292 or 212-983-9330 (Ext. 1310).\n\n[You may also click here for additional information]\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=86675342&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=%5BYou+may+also+click+here+for+additional+information%5D)\n\nNEW YORK, May 1, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1030381571&u=https%3A%2F%2Fwww.faruqilaw.com%2F&a=Faruqi+%26+Faruqi%2C+LLP)\n, a leading national securities law firm, is investigating potential claims\nagainst Gossamer Bio, Inc. (\"Gossamer\" or the \"Company\") (NASDAQ: GOSS) and\nreminds investors of the June 1, 2026 deadline to seek the role of lead\nplaintiff in a federal securities class action that has been filed against the\nCompany.\n\n(https://mma.prnewswire.com/media/2457438/Faruqi_Logo.html)\n\nFaruqi & Faruqi is a leading national securities law firm with offices in\nNew York, Pennsylvania, California and Georgia. The firm has recovered\nhundreds of millions of dollars for investors since its founding in 1995. See\nwww.faruqilaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=601935371&u=https%3A%2F%2Fwww.faruqilaw.com%2F&a=www.faruqilaw.com)\n.\n\nAs detailed below, the complaint alleges that the Company and its executives\nviolated federal securities laws by making false and/or misleading statements\nand/or failing to disclose that the study design for the Company's Phase 3\nPROSERA study, particularly, controlling for the placebo response at the Latin\nAmerican testing sites.\n\nOn February 23, 2026, Gossamer Bio, Inc. revealed adverse topline results from\nits Phase 3 PROSERA study, announcing that the trial failed to meet its\nprimary endpoint of improving six-minute walk distance (\"6MWD\") at Week 24.\nWhile the study reported a placebo-adjusted gain of +13.3 meters, the result\ndid not achieve statistical significance under the prespecified alpha\nthreshold of 0.025 (p=0.0320). The Company attributed the outcome, in part, to\nunexpectedly strong placebo performance among patients enrolled at Latin\nAmerican sites, which it characterized as a heavily treated, lower-risk\npopulation.\n\nFollowing this disclosure, investors and analysts reacted swiftly and\nnegatively. On February 23, 2026, Gossamer's common stock price plummeted from\na closing price of $2.13 per share on February 20, 2026 to $0.42 per share,\nrepresenting a decline of more than 80% in a single trading day.\n\nThe court-appointed lead plaintiff is the investor with the largest financial\ninterest in the relief sought by the class who is adequate and typical of\nclass members who directs and oversees the litigation on behalf of the\nputative class. Any member of the putative class may move the Court to serve\nas lead plaintiff through counsel of their choice, or may choose to do nothing\nand remain an absent class member. Your ability to share in any recovery is\nnot affected by the decision to serve as a lead plaintiff or not.\n\nFaruqi & Faruqi, LLP also encourages anyone with information regarding\nGossamer's conduct to contact the firm, including whistleblowers, former\nemployees, shareholders and others.\n\nTo learn more about the Gossamer Bio class action, go to\nwww.faruqilaw.com/GOSS\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1719973099&u=https%3A%2F%2Fwww.faruqilaw.com%2FGOSS&a=www.faruqilaw.com%2FGOSS)\nor call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or\n212-983-9330 (Ext. 1310).\n\nFollow us for updates on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=672128528&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ffaruqi-%26-faruqi-llp%2F&a=LinkedIn)\n, on X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=1346472736&u=https%3A%2F%2Fx.com%2Ffaruqilaw&a=X)\n, or on Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3798677373&u=https%3A%2F%2Fwww.facebook.com%2FFaruqiLaw%2F&a=Facebook)\n.\n\nAttorney Advertising. The law firm responsible for this advertisement is\nFaruqi & Faruqi, LLP (www.faruqilaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4677940-1&h=3895810712&u=http%3A%2F%2Fwww.faruqilaw.com%2F&a=www.faruqilaw.com)\n). Prior results do not guarantee or predict a similar outcome with respect to\nany future matter. We welcome the opportunity to discuss your particular case.\nAll communications will be treated in a confidential manner.\n\n(https://mma.prnewswire.com/media/2745617/Faruqi__Faruqi_LLP_James_Josh_Wilson.html)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/goss-shareholder-reminder-faruqi--faruqi-llp-reminds-gossamer-bio-goss-investors-of-securities-class-action-deadline-on-june-1-2026-302759781.html\n(https://www.prnewswire.com/news-releases/goss-shareholder-reminder-faruqi--faruqi-llp-reminds-gossamer-bio-goss-investors-of-securities-class-action-deadline-on-june-1-2026-302759781.html)\n\nSOURCE Faruqi & Faruqi, LLP\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2457438/Faruqi_Logo.jpg\nhttps://mma.prnewswire.com/media/2745617/Faruqi__Faruqi_LLP_James_Josh_Wilson.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-01T14:03:00.068454784Z","server_sent_at_ms":1777644180068},"received_at":"2026-05-01T14:03:00.125Z","source_url":"https://www.prnewswire.com/news-releases/goss-shareholder-reminder-faruqi--faruqi-llp-reminds-gossamer-bio-goss-investors-of-securities-class-action-deadline-on-june-1-2026-302739532.html"},"analysis":{"id":"12681","press_release_id":"17230","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Faruqi & Faruqi, LLP issued a shareholder reminder regarding Gossamer Bio, urging investors who suffered losses to contact the firm before the June 1, 2026 lead plaintiff deadline.\n\nThe solicitation references the previously reported failure of the Phase 3 PROSERA study, which triggered an 80% single-day stock decline in late February 2026.\n\nThis release is a law-firm advertisement seeking class representatives and does not constitute new disclosure from the company.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"reminds investors of the June 1, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.","namedEntities":{"people":[{"name":"James (Josh) Wilson","role":"Partner"}],"products":["PROSERA"],"companies":[{"name":"Faruqi & Faruqi, LLP","relationship":"plaintiff law firm"},{"name":"Gossamer Bio, Inc.","ticker":"GOSS","relationship":"target"}],"dollarAmounts":[{"amount":"$2.13","context":"closing price on February 20, 2026"},{"amount":"$0.42","context":"stock price on February 23, 2026"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Faruqi & Faruqi, LLP. No new disclosure from the issuer; routine lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"GOSS"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Faruqi & Faruqi, LLP issued a shareholder reminder regarding Gossamer Bio, urging investors who suffered losses to contact the firm before the June 1, 2026 lead plaintiff deadline.\n\nThe solicitation references the previously reported failure of the Phase 3 PROSERA study, which triggered an 80% single-day stock decline in late February 2026.\n\nThis release is a law-firm advertisement seeking class representatives and does not constitute new disclosure from the company.","key_figures":{},"named_entities":{"people":[{"name":"James (Josh) Wilson","role":"Partner"}],"products":["PROSERA"],"companies":[{"name":"Faruqi & Faruqi, LLP","relationship":"plaintiff law firm"},{"name":"Gossamer Bio, Inc.","ticker":"GOSS","relationship":"target"}],"dollarAmounts":[{"amount":"$2.13","context":"closing price on February 20, 2026"},{"amount":"$0.42","context":"stock price on February 23, 2026"}]},"model_name":"glm-4.7","prompt_hash":"sha256:a2703c5a1b5285fe","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-05-01T14:50:31.182Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":78024,"modelName":"glm-4.7"}}